Adenoid cystic carcinoma of lung: An oncologic rarity treated with definitive chemo-radiation
Adenoid Cystic Carcinoma is a rare variant of adenocarcinoma originating mainly from salivary glands of the head and neck region distributed throughout the upper aerodigestive tract with a propensity for perineural invasion. Primary adenoid cystic carcinoma of lungs is exceedingly rare accounting for a mere 0.04 to 0.2 percent of all pulmonary neoplasms. The existing scant case reports about this lung malignancy mostly describe small lung lesions managed with upfront surgery followed by adjuvant radiotherapy. We hereby present this case of primary lung parenchymal pathology where the disease was treated with definitive chemo-radiation and to the best of our knowledge; this case is one of the rarest and earliest reports of upfront chemo-radiation in an inoperable primary lung parenchymal ACC. A 43-year-old woman presented with complaints of cough, severe dyspnea, right sided chest pain associated with occasional hemoptysis. Radiographic imaging of thorax showed a large mass lesion with smooth margins measuring 10.2 × 7.3 × 6.8 cm right lower lobe with invasion of adjacent vital structures. Image guided biopsy and immunohistochemical analysis confirmed the diagnosis. She was eventually treated with definitive radiotherapy with concurrent chemotherapy as she was deemed inoperable. Post therapy evaluation by imaging showed a partial response to chemo-radiation, however there was significant symptomatic relief. In view of CD 117 positivity, she has started on oral imatinib mesylate. Presently she is on follow up with a karnofsky performance status of 90%. A thorough review of literature also reveals that our case may be the largest adenoid cystic primary parenchymal pulmonary pathology ever reported.
Barnes L, Eveson JW, Reichart P et al. Pathology and genetics: head and neck tumours. In: Kleihues P, Sobin LH, series, editors World Health Organization Classification of Tumours. Lyon: IARC Press. 2005.
Molina JR, Aubry MC, Lewis JE et al. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer. 2007;110:2253-9.
Kim JH, Ahn SH, Kim JM et al. Metachronous adenoid cystic carcinoma in the peripheral lung and at base of the tongue. Clin Exp Otorhinolaryngol. 2014;7:232-5.
Travis WD, Travis LB and Devesa SS. Lung cancer. Cancer. 1995;75:191-202.
Qiu S, Nampoothiri MM, Zaharopoulos P et al. Primary pulmonary adenoid cystic carcinoma: report of a case diagnosed by fine-needle aspiration cytology. Diagn Cytopathol. 2004;30: 51-6.
Inoue H, Iwashita A, Kanegae H et al. Peripheral pulmonary adenoid cystic carcinoma with substantial submucosal extension to the proximal bronchus. Thorax. 1991;46:147-8.
Fields JN, Rigaud G, Emami BN: Primary tumors of the trachea: Results of radiation therapy. Cancer. 1989; 63:2429-33.
Etori F, Watanabe N, Matsuyama M et al. Primary adenoid cystic carcinoma in the peripheral lung: a cytological, histopathological and immunohistochemical report of two cases. Pathol Discov. 2015;3(3):1-7.
Hotte SJ, Winquist EW, Lamont E et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol. 2005;23:585-90.
Faivre S, Raymond E, Casiraghi O et al. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol. 2005;23:6271-3.
Allen AM, Rabin MS, Reilly JJ et al. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiation. J Clin Oncol. 2007;25(34):5521-3.
Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997;174: 495-8.
Sweeney WB and Thomas JM. Adenoid cystic carcinoma of the lung. Contemp. Surg.1986; 28:97-100.
Hu M M, Hu Y, He J B et al. Primary adenoid cystic carcinoma of the lung: Clinicopathological features, treatment and results. Oncology Letters. 2015;9(3):1475-81.
Moran CA, Suster S, Koss MN. Primary adenoid cystic carcinoma of the lung. A clinicopathologic and immunohistochemical study of 16 cases. Cancer. 1994;73:1390–7.
Holst VA, Marshall CE, Moskaluk CA et al. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol.1999;12:956-60.
Sasiaja M, Funa N, Kamata M et al. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiotherapy. Clin Oncol R Coll Radio. 2000;12:272.
Videtic GM, Campbell C, Vincent MD: Primary chemoradiation as definitive treatment for unresectable cancer of the trachea. Can Respir J. 2003;10:143-4.
Dammrich DJ, Santos ES, Raez LE. Efficacy of sorafenib, a multi-tyrosine kinase inhibitor, in an adenoid cystic carcinoma metastatic to the lung: case report and review of literature. J Med Case Rep. 2011;5:483.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.